title: Depression of cell-mediated immunity in plasmacytoma-bearing mice.
abstract: Previous reports have documented that mice bearing plasmacytomas (PC) are suppressed in their ability to mount a primary antibody response, whereas cellular immunity appears to be normal. Studies presented here provide evidence that T cell responsiveness is also depressed in BALB/c mice bearing the Lieberman plasmacytoma (Lpc-1). For instance, splenocytes from mice bearing large tumours were impaired in their in vitro ability to respond to the T cell mitogen, mount an appropriate alloreactive cytolytic T lymphocyte response, and produce interleukin-2 (IL-2). A population of suppressor cells was detected in the spleens 7 days after tumour implantation as evidenced by their ability to prevent normal splenocytes not only from responding to antigens in mixed lymphocyte culture, but also from producing IL-2. A similar inhibitory effect was observed with culture supernatants of these cells, indicating the existence of a soluble suppressive factor. Therefore, the present study demonstrates that cellular immune responses are impaired in mice bearing Lpc-1 tumours and that this effect may be due to the generation of suppressor cells and/or a suppressive factor.
authors.affiliation: Chemotherapy Research Department, American Cyanamid Company, Lederle Laboratories, Pearl River, New York 10965.
authors.forename: V
authors.initials: V
authors.lastname: Ruszala-Mallon
authors.forename: J
authors.initials: J
authors.lastname: Silva
authors.forename: A L
authors.initials: AL
authors.lastname: Lumanglas
authors.forename: F E
authors.initials: FE
authors.lastname: Durr
authors.forename: B S
authors.initials: BS
authors.lastname: Wang
mesh_terms: D000818:Animals; D006133:Growth Substances / Q000276:immunology; D007111:Immunity, Cellular; D007376:Interleukin-2 / Q000276:immunology; D007519:Isoantigens / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D009000:Monocytes / Q000502:physiology*; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000209:etiology / Q000276:immunology*; D010954:Plasmacytoma / Q000209:etiology / Q000276:immunology*; D013154:Spleen / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology; D013997:Time Factors
chemical_list: D006133:Growth Substances; D007376:Interleukin-2; D007519:Isoantigens